Meyer Handelman CO Becton Dickinson & CO Transaction History

Meyer Handelman CO

$2.84 Billion
Q1 2025

A detailed history of Meyer Handelman CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Meyer Handelman CO holds 8,316 shares of BDX stock, worth $1.42 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

8,316

Previous 10,676 22.11%

Holding current value

$1.42 Million

Previous $2.42 Million 21.39%

% of portfolio

0.07%

Previous 0.08%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$222.79 - $249.08 $525,784 - $587,828	-2,360 Reduced 22.11%	8,316 $1.9 Million
Q4 2024 Jan 14, 2025	SELL	$220.02 - $243.75 $301,427 - $333,937	-1,370 Reduced 11.37%	10,676 $2.42 Million
Q4 2022 Jan 25, 2023	SELL	$218.29 - $256.91 $1.17 Million - $1.38 Million	-5,361 Reduced 30.8%	12,046 $3.06 Million
Q1 2021 May 03, 2021	SELL	$232.09 - $256.88 $12,764 - $14,128	-55 Reduced 0.31%	17,407 $4.23 Million
Q4 2020 Feb 03, 2021	BUY	$221.92 - $245.94 $12,205 - $13,526	55 Added 0.32%	17,462 $4.37 Million
Q1 2019 Apr 30, 2019	SELL	$206.05 - $248.17 $2.27 Million - $2.73 Million	-11,000 Reduced 38.72%	17,407 $4.35 Million
Q3 2018 Nov 06, 2018	SELL	$233.07 - $256.0 $550,278 - $604,416	-2,361 Reduced 7.67%	28,407 $7.41 Million
Q2 2018 Jul 30, 2018	SELL	$208.1 - $233.85 $283,224 - $318,269	-1,361 Reduced 4.24%	30,768 $7.37 Million
Q1 2018 Apr 23, 2018	SELL	$205.46 - $240.27 $821 - $961	-4 Reduced 0.01%	32,129 $6.96 Million
Q4 2017 Feb 07, 2018	BUY	$189.0 - $222.64 $6.07 Million - $7.15 Million	32,133	32,133 $6.88 Million

Others Institutions Holding BDX

# of Institutions

1,806

Shares Held

257M

Call Options Held

3.24M

Put Options Held

841K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $48.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Becton Dickinson & CO Transaction History